Improving patient recruitment to randomised trials can be cost-effective: A case-study of dexamethasone from the RECOVERY trial.

Improving patient recruitment to randomised trials can be cost-effective: A case-study of dexamethasone from the RECOVERY trial.

<h4>Background</h4>The RECOVERY trial assessed the effectiveness of treatments on preventing severe outcomes from COVID-19 disease in hospitalised patients from 176 NHS hospitals. Clinical benefits of Dexamethasone were observed for hospitalised COVID-19 patients. About 15% of all eligib...

Full description

Saved in:
Bibliographic Details
Main Authors: Athanasios Gkekas, Sarah J Ronaldson, Adwoa Parker, David J Torgerson
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0314593
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items